肝移植受者中 E2SKAPE 感染和死亡率的风险因素。

IF 3.2 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Xiaoxia Wu, Chenpeng Xie, Weiting Peng, Jie Zhao, Lin Shu, Manjie Guo, Qiquan Wan
{"title":"肝移植受者中 E2SKAPE 感染和死亡率的风险因素。","authors":"Xiaoxia Wu, Chenpeng Xie, Weiting Peng, Jie Zhao, Lin Shu, Manjie Guo, Qiquan Wan","doi":"10.1016/j.clinthera.2024.08.017","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Infections caused by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp (ESKAPE) plus Escherichia coli (E<sub>2</sub>SKAPE), in particular multidrug-resistant (MDR) E<sub>2</sub>SKAPE infections, occur frequently and pose a life-threatening to liver transplant (LT) recipients. To prevent E<sub>2</sub>SKAPE infections and improve the prognosis of LT recipients, the identification of risk factors for E<sub>2</sub>SKAPE infections and mortality is necessary.</p><p><strong>Methods: </strong>E<sub>2</sub>SKAPE pathogens were isolated and identified from clinical samples following standard microbiological procedures. All episodes of E<sub>2</sub>SKAPE infections and mortality documented among LT recipients were analyzed.</p><p><strong>Findings: </strong>A total of 83 episodes of E<sub>2</sub>SKAPE infections, including 75 (90.4%) episodes of MDR-E<sub>2</sub>SKAPE infections, occurred in 23.1% (53/229) of LT recipients. E. faecium was the dominant causative bacterium (37/83; 44.6%). The most common site of infections was the urinary tract (14/53; 26.4%). Sixteen (7%) patients died within 2 months after LT, and 7 deaths were E<sub>2</sub>SKAPE infections-related. Multivariate logistic regression analysis revealed that female sex [odds ratio (OR) = 3.665, 95% confidence interval (CI): 1.614-8.321, P = 0.002], duration of surgery ≥ 400 min [OR = 2.328, 95%CI: 1.151-4.707, P = 0.019], intraoperative red blood cell (RBC) transfusion ≥ 12U [OR = 2.542, 95%CI: 1.218-5.306, P = 0.013] and indwelling urethral catheter use ≥ 3 days [OR = 3.96, 95%CI: 1.309-11.981, P = 0.015] were independent risk factors for E<sub>2</sub>SKAPE infections after LT, and that only exposure to more than 2 intravenous antibiotics post-LT [OR = 0.318, 95%CI: 0.15-0.674, P = 0.003] was negatively associated with acquisition of E<sub>2</sub>SKAPE infections. The predictors of crude mortality included female sex [OR = 4.822, 95%CI: 1.299-17.904, P = 0.019], creatinine on day 3 post-LT > 1.5 mg/dL [OR = 11.014, 95%CI: 2.985-40.637, P < 0.001], mechanical ventilation post-LT [OR = 10.724, 95%CI: 2.695-42.676, P = 0.001] and recipients with E<sub>2</sub>SKAPE infections [OR = 4.112, 95%CI: 1.169-14.47, P = 0.028].</p><p><strong>Implications: </strong>A high incidence of E<sub>2</sub>SKAPE infections was noted in the early post-LT period. The most common infection site was the urinary tract, and the dominant pathogenic bacterium was E. faecium. Female sex, prolonged surgery time, massive RBC transfusion, or delayed urethral catheter removal were associated with E<sub>2</sub>SKAPE infections. Only exposure to more than 2 intravenous antibiotics post-LT was negatively related to the acquisition of E<sub>2</sub>SKAPE infections. The predictors of mortality included female sex, creatinine on day 3 post-LT>1.5 mg/dL, mechanical ventilation post-LT, and recipients with E<sub>2</sub>SKAPE infections.</p>","PeriodicalId":10699,"journal":{"name":"Clinical therapeutics","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk Factors for E<sub>2</sub>SKAPE Infections and Mortality Among Liver Transplant Recipients.\",\"authors\":\"Xiaoxia Wu, Chenpeng Xie, Weiting Peng, Jie Zhao, Lin Shu, Manjie Guo, Qiquan Wan\",\"doi\":\"10.1016/j.clinthera.2024.08.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Infections caused by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp (ESKAPE) plus Escherichia coli (E<sub>2</sub>SKAPE), in particular multidrug-resistant (MDR) E<sub>2</sub>SKAPE infections, occur frequently and pose a life-threatening to liver transplant (LT) recipients. To prevent E<sub>2</sub>SKAPE infections and improve the prognosis of LT recipients, the identification of risk factors for E<sub>2</sub>SKAPE infections and mortality is necessary.</p><p><strong>Methods: </strong>E<sub>2</sub>SKAPE pathogens were isolated and identified from clinical samples following standard microbiological procedures. All episodes of E<sub>2</sub>SKAPE infections and mortality documented among LT recipients were analyzed.</p><p><strong>Findings: </strong>A total of 83 episodes of E<sub>2</sub>SKAPE infections, including 75 (90.4%) episodes of MDR-E<sub>2</sub>SKAPE infections, occurred in 23.1% (53/229) of LT recipients. E. faecium was the dominant causative bacterium (37/83; 44.6%). The most common site of infections was the urinary tract (14/53; 26.4%). Sixteen (7%) patients died within 2 months after LT, and 7 deaths were E<sub>2</sub>SKAPE infections-related. Multivariate logistic regression analysis revealed that female sex [odds ratio (OR) = 3.665, 95% confidence interval (CI): 1.614-8.321, P = 0.002], duration of surgery ≥ 400 min [OR = 2.328, 95%CI: 1.151-4.707, P = 0.019], intraoperative red blood cell (RBC) transfusion ≥ 12U [OR = 2.542, 95%CI: 1.218-5.306, P = 0.013] and indwelling urethral catheter use ≥ 3 days [OR = 3.96, 95%CI: 1.309-11.981, P = 0.015] were independent risk factors for E<sub>2</sub>SKAPE infections after LT, and that only exposure to more than 2 intravenous antibiotics post-LT [OR = 0.318, 95%CI: 0.15-0.674, P = 0.003] was negatively associated with acquisition of E<sub>2</sub>SKAPE infections. The predictors of crude mortality included female sex [OR = 4.822, 95%CI: 1.299-17.904, P = 0.019], creatinine on day 3 post-LT > 1.5 mg/dL [OR = 11.014, 95%CI: 2.985-40.637, P < 0.001], mechanical ventilation post-LT [OR = 10.724, 95%CI: 2.695-42.676, P = 0.001] and recipients with E<sub>2</sub>SKAPE infections [OR = 4.112, 95%CI: 1.169-14.47, P = 0.028].</p><p><strong>Implications: </strong>A high incidence of E<sub>2</sub>SKAPE infections was noted in the early post-LT period. The most common infection site was the urinary tract, and the dominant pathogenic bacterium was E. faecium. Female sex, prolonged surgery time, massive RBC transfusion, or delayed urethral catheter removal were associated with E<sub>2</sub>SKAPE infections. Only exposure to more than 2 intravenous antibiotics post-LT was negatively related to the acquisition of E<sub>2</sub>SKAPE infections. The predictors of mortality included female sex, creatinine on day 3 post-LT>1.5 mg/dL, mechanical ventilation post-LT, and recipients with E<sub>2</sub>SKAPE infections.</p>\",\"PeriodicalId\":10699,\"journal\":{\"name\":\"Clinical therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.clinthera.2024.08.017\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clinthera.2024.08.017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的:由粪肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌(ESKAPE)加大肠埃希菌(E2SKAPE)引起的感染,尤其是耐多药(MDR)E2SKAPE感染,经常发生并威胁肝移植(LT)受者的生命。为了预防E2SKAPE感染并改善LT受者的预后,有必要确定E2SKAPE感染和死亡率的风险因素:方法:按照标准微生物学程序从临床样本中分离并鉴定 E2SKAPE 病原体。方法:按照标准微生物程序从临床样本中分离和鉴定 E2SKAPE 病原体,并对所有记录在案的接受长期治疗者的 E2SKAPE 感染和死亡病例进行分析:23.1%(53/229)的LT受者共发生83例E2SKAPE感染,包括75例(90.4%)MDR-E2SKAPE感染。粪肠球菌是主要的致病菌(37/83;44.6%)。最常见的感染部位是尿路(14/53;26.4%)。16例(7%)患者在LT术后2个月内死亡,其中7例死亡与E2SKAPE感染有关。多变量逻辑回归分析显示,女性[几率比(OR)= 3.665,95% 置信区间(CI):1.614-8.321,P = 0.002]、手术时间≥ 400 分钟[OR = 2.328,95%CI:1.151-4.707,P = 0.019]、术中输注红细胞(RBC)≥ 12U [OR = 2.542,95%CI:1.218-5.306,P = 0.013] 和留置尿道导尿管使用≥ 3 天 [OR = 3.96,95%CI:1.309-11.981,P = 0.015] 是 LT 后 E2SKAPE 感染的独立危险因素,只有在 LT 后接触超过 2 种静脉注射抗生素 [OR = 0.318,95%CI:0.15-0.674,P = 0.003] 与 E2SKAPE 感染的获得呈负相关。粗死亡率的预测因素包括女性[OR = 4.822,95%CI:1.299-17.904,P = 0.019]、LT 后第 3 天肌酐 > 1.5 mg/dL [OR = 11.014,95%CI:2.985-40.637,P < 0.001]、LT 后机械通气[OR = 10.724,95%CI:2.695-42.676,P = 0.001]和受者 E2SKAPE 感染[OR = 4.112,95%CI:1.169-14.47,P = 0.028]:LT术后早期的E2SKAPE感染率较高。最常见的感染部位是尿路,主要致病菌是粪大肠杆菌。女性性别、手术时间延长、大量输注红细胞或延迟拔除尿道导管与 E2SKAPE 感染有关。只有在 LT 后静脉注射 2 种以上抗生素才与 E2SKAPE 感染呈负相关。预测死亡率的因素包括女性、LT 后第 3 天的肌酐>1.5 mg/dL、LT 后的机械通气以及受者的 E2SKAPE 感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Risk Factors for E2SKAPE Infections and Mortality Among Liver Transplant Recipients.

Purpose: Infections caused by Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp (ESKAPE) plus Escherichia coli (E2SKAPE), in particular multidrug-resistant (MDR) E2SKAPE infections, occur frequently and pose a life-threatening to liver transplant (LT) recipients. To prevent E2SKAPE infections and improve the prognosis of LT recipients, the identification of risk factors for E2SKAPE infections and mortality is necessary.

Methods: E2SKAPE pathogens were isolated and identified from clinical samples following standard microbiological procedures. All episodes of E2SKAPE infections and mortality documented among LT recipients were analyzed.

Findings: A total of 83 episodes of E2SKAPE infections, including 75 (90.4%) episodes of MDR-E2SKAPE infections, occurred in 23.1% (53/229) of LT recipients. E. faecium was the dominant causative bacterium (37/83; 44.6%). The most common site of infections was the urinary tract (14/53; 26.4%). Sixteen (7%) patients died within 2 months after LT, and 7 deaths were E2SKAPE infections-related. Multivariate logistic regression analysis revealed that female sex [odds ratio (OR) = 3.665, 95% confidence interval (CI): 1.614-8.321, P = 0.002], duration of surgery ≥ 400 min [OR = 2.328, 95%CI: 1.151-4.707, P = 0.019], intraoperative red blood cell (RBC) transfusion ≥ 12U [OR = 2.542, 95%CI: 1.218-5.306, P = 0.013] and indwelling urethral catheter use ≥ 3 days [OR = 3.96, 95%CI: 1.309-11.981, P = 0.015] were independent risk factors for E2SKAPE infections after LT, and that only exposure to more than 2 intravenous antibiotics post-LT [OR = 0.318, 95%CI: 0.15-0.674, P = 0.003] was negatively associated with acquisition of E2SKAPE infections. The predictors of crude mortality included female sex [OR = 4.822, 95%CI: 1.299-17.904, P = 0.019], creatinine on day 3 post-LT > 1.5 mg/dL [OR = 11.014, 95%CI: 2.985-40.637, P < 0.001], mechanical ventilation post-LT [OR = 10.724, 95%CI: 2.695-42.676, P = 0.001] and recipients with E2SKAPE infections [OR = 4.112, 95%CI: 1.169-14.47, P = 0.028].

Implications: A high incidence of E2SKAPE infections was noted in the early post-LT period. The most common infection site was the urinary tract, and the dominant pathogenic bacterium was E. faecium. Female sex, prolonged surgery time, massive RBC transfusion, or delayed urethral catheter removal were associated with E2SKAPE infections. Only exposure to more than 2 intravenous antibiotics post-LT was negatively related to the acquisition of E2SKAPE infections. The predictors of mortality included female sex, creatinine on day 3 post-LT>1.5 mg/dL, mechanical ventilation post-LT, and recipients with E2SKAPE infections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical therapeutics
Clinical therapeutics 医学-药学
CiteScore
6.00
自引率
3.10%
发文量
154
审稿时长
9 weeks
期刊介绍: Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信